FDA places clinical hold on Regenxbio's RGX-121 gene therapy for Hunter Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to FDA places clinical hold on Regenxbio's RGX-121 gene therapy for Hunter Syndrome

Regenxbio (RGNX) to Resume Trading at 7:25 am ET

August 24, 2026 7:13 AM EDT

Regenxbio (NASDAQ: RGNX) to Resume Trading at 7:25 am ET

... More